EverCommerce Inc. (EVCM) Earnings

EverCommerce Inc. is expected to report next earnings on August 5, 2026 (in NaN days), with a consensus EPS estimate of $0.16. EVCM has beaten EPS estimates in 1 of its last 11 reported quarters (average surprise +75.3% over the last four).

Next earnings
Aug 5, 2026in NaN days
EPS est $0.16 · Revenue est $152M
Track record
Beat EPS in 1 of 11 quarters
Avg surprise +75.3% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 7, 2026$0.14$0.04-71.9%$147M+0.2%
Mar 12, 2026$0.05$0.03-27.0%$151M+0.7%
Nov 6, 2025$0.03$0.03+0.0%$147M-1.7%
Aug 6, 2025$-0.01$0.03+400.0%$148M+0.0%
May 8, 2025$0.04$0.01-75.0%$142M-2.7%
Mar 13, 2025$0.02$-0.07-450.0%$175M+16.9%
May 9, 2024$-0.06$-0.09-50.0%$170M+4.9%
Mar 14, 2024$-0.09$-0.12-28.4%$169M-1.7%
Mar 15, 2023$0.09$-0.04-144.4%$162M+2.0%
Nov 10, 2022$0.09$-0.04-144.4%$158M-1.3%
Mar 14, 2022$0.07$-0.01-114.3%$136M+4.0%
Jul 6, 2021$-0.08$105M

Source: company filings + earnings calendar. For informational purposes only — not investment advice.

Earnings call summary

Q1 FY2026 · May 7, 2026

AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.

Management highlights

- Had a strong start to the year, focused on investing in AI and go-to-market capabilities. - Cross-sell motion expanded with 32% growth in customers utilizing more than one solution. - Shared customer examples of AI use cases: Coast to Coast HTM using Service Fusion and ZyraTalk AI integration, and a solo orthopedic surgeon in EverHealth using AI scribe. - Multi-product adoption remains a key growth driver, with multi-product customers generating higher revenue, stronger retention, and expanded wallet share. - Payment strategy focuses on enabling payments at SaaS sale and driving cross-sale, with top six solutions showing strong TPV and payments revenue growth.

Guidance

- Q2 2026: Expected total revenue of $150.5 million to $153.5 million and adjusted EBITDA of $41 million to $43 million. - Full year 2026: Reiterates previous guidance with revenue of $612 million to $632 million and adjusted EBITDA of $183 million to $191 million.

Segment performance

In the first quarter, EverCommerce generated revenue of $147.5 million, with adjusted EBITDA of $40.7 million. Subscription and transaction revenue, the primary recurring revenue base, was $142.1 million. Proforma revenue, adjusted for the acquisition of ZyraTalk, was $596 million on an LTM basis. The two verticals EverPro and EverHealth represent approximately 95% of consolidated revenue.

Risks & headwinds

No detailed specific risk discussion in the transcript beyond the general safe harbor statement noting that actual results may differ from forward-looking statements due to risks and uncertainties in SEC filings.

Analyst Q&A

  • Q: Great to see the customer example leveraging ZaraTalk. Talk about cross-selling ZaraTalk into the overall customer base.

    A: Matt mentions ZaraTalk is a foundational capability integrated into customer-facing use cases, already integrated with Service Fusion and BrioStack ahead of schedule, with great customer reception and internal experimentation in areas like AI-driven surveys.

  • Q: On new customer velocity and top of funnel trends.

    A: Evan and Matt discuss strong demand, sales cycles trending down, shift to more outbound, stable demand for EverPro, and maturation of EverHealth and EverPro businesses.

  • Q: How thinking about cadence of share repurchases.

    A: Brad says share repurchase program is set on schedule, re-purchasing shares is accretive use of capital.

  • Q: On EverHealth AI Scribe adoption and differentiation.

    A: Bill is told differentiation is the great integrated solution, robust roadmap, large opportunity, and doubling of customer ARPU with products like Scribe and payments.